Rapid Dose Therapeutics Closes First Tranche of Private Placement
BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is pleased to announce the closing of the first tranche of a Private Placement. The tranche consists of 506,157 Common Share Units at a price of $0.30 per Unit for net proceeds to the Company … [Read more…]